Exposure-disease continuum for 2-chloro-2′-deoxyadenosine (2-CdA), a prototype teratogen: Induction of lumbar hernia in the rat and species comparison for the teratogenic responses

Teratology

Volumn 66, Issue 1, 2002, Pages 6-18

  Lau, Christopher ^a   Narotsky, Michael G ^a   Lui, Doris ^a   Best, Deborah ^a   Woodrow Setzer, R ^a   Mann, Peter C ^b   Wubah, Judith A ^c   Knudsen, Thomas B ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HYPOPLASIA; INTERVERTEBRAL DISK HERNIA; KIDNEY MALFORMATION; LUMBAR SPINE; MATERNAL SERUM; MICROPHTHALMIA; MUSCLE MALFORMATION; NONHUMAN; POLYDACTYLY; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; RIB MALFORMATION; SOFT TISSUE DISEASE; SPINA BIFIDA; SURVIVAL; TERATOGENICITY; TERATOLOGY; TRUNK; UROGENITAL TRACT MALFORMATION; ANIMAL; BACK; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EYE MALFORMATION; HERNIA; SPINAL CORD DISEASE; SPRAGUE DAWLEY RAT;

ANIMAL; CLADRIBINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE ABNORMALITIES; FEMALE; HERNIA; LUMBOSACRAL REGION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD DISEASES; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TERATOGENS; ANIMALS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0036019235     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10039     Document Type: Article

References (44)

1. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels
2. Focal nodular hyperplasia of the liver with the lumbar-costovertebral syndrome
3. Benchmark Dose Workshop: Criteria for use of a benchmark dose to estimate a reference dose
4. Superior lumbar hernia associated with the lumbocostovertebral syndrome
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Arnold-Chiari-like malformation associated with a valproate model of spina bifida in the rat
7. Differences in deoxycytidine metabolism in mouse and rat
8. The embryonic development of mammalian neural tube defects
9. A new method for determining allowable daily intakes
10. Valproic acid-induced spina bifida: A mouse model
11. Observations and current operative management of congenital lumbar hernias during infancy
12. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria
13. A language for data analysis and graphics
14. Experimental production of congenital anomalies: Timing and degree of anoxia as factors causing fetal deaths and congenital anomalies in the mouse
15. Mitochondrial and submitochondrial localization of human deoxyguanosine kinase
16. Nucleotide pool imbalance
17. Biologically based risk assessment models for developmental toxicity
18. Toward a biologically-based dose-response model for developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data
19. Lumbar hernia as congenital aplasia of lumbo-dorsal muscle
20. Nonlinear mixed effects models for repeated measures data
21. Lumbar herniation and tibial absence in infants of diabetic mothers
22. Developmental toxicity of 2-chloro-2′-deoxyadenosine (2-CdA, cladribine)
23. Congenital lumbar and sciatic herniae in an infant
24. Examination of the axial skeleton of fetal rodents
25. 2-Chloro-2′-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4
26. Congenital lumbar (Grynfelt-Lesshaft) hernia
27. Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase 1 pharmacologically directed dose-escalation concept for 2-chloro-2′-deoyxadenosine
28. On parameter redundancy in curve fitting of kinetic data
29. Toward a biologically-based dose-response model for developmental toxicity of 5-fluorouracil in the rat: A mathematical construct
30. Biologically-based dose-response modeling in developmental toxicology: Biochemical and cellular sequelae of 5-FU exposure in the rat fetus
31. Spontaneous lateral abdominal (lumbar) hernia in a New Zealand white rabbit
32. Teratogenic effect of chlormadinone acetate in mice and rabbits
33. The lumbocostovertebral syndrome: A single somatic defect
34. Substrate specificity of mitochondrial 2′-deoxyadenosine kinase: Efficient phosphorylation of 2-chloroadenosine
35. Cloning and expression of human mitochondrial deoxyguanosine kinase cDNA
36. Methods for administering agents and detecting malformations in experimental animals
37. Teratogen-induced eye defects mediated by p53-dependent apoptosis
38. Exposure-disease continuum for 2-chloro-2′-deoxyadenosine, a prototype ocular teratogen. 1. Dose-response analysis
39. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines